LINC01816

Across TCGA pan-cancer cohorts, LINC01816 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01816’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where LINC01816 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01816 is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

KICH, HNSC, and LUSC are the cancer types where LINC01816 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01816 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Male	All	−1.667	<.001	10	view →
HNSC	All	II,III,IV	+0.518	<.001	10	view →
LUSC	All	II,III,IV	+1.008	<.001	6	view →
LUAD	Male	All	+0.909	<.001	6	view →
KIRP	All	All	−0.666	<.001	6	view →
COAD	All	II,III,IV	+0.493	.001	6	view →
KIRC	Male	II,III,IV	−0.467	<.001	6	view →
LIHC	Male	All	+0.792	<.001	4	view →
STAD	All	II,III,IV	+0.640	.016	3	view →
CHOL	All	All	−0.928	.006	2	view →
PRAD	All	All	+0.355	.005	2	view →
BLCA	Female	IV	+1.356	.008	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01816–KICH

Open the KICH breakdown →